Guidelines : Drug monitoring
Detail
Condition :
Drug monitoring
Keywords :
renal function, digoxin, ACEi, ACE inhibitors, NSAIDs, ARBs, diuretics, adverse drug reactions,
BNF Codes :
Committee Recommendations
Date
Committee Name
Narrative
Traffic Light Status
01 March 2017
The MCG concluded that the Drug Monitoring Summary document was a useful resource and should be made available for CCGs to adopt as appropriate.
The Monitoring Drug Therapy guide below provides advice on the monitoring requirements for a number of drugs associated with hospital admissions for adverse drug reactions:
o ACE inhibitors and angiotensin II receptor antagonists
o Digoxin
o NSAIDs (including COX IIs)
o Diuretics
The Monitoring Drug Therapy guide below provides advice on the monitoring requirements for a number of drugs associated with hospital admissions for adverse drug reactions:
o ACE inhibitors and angiotensin II receptor antagonists
o Digoxin
o NSAIDs (including COX IIs)
o Diuretics
N/A
03 February 2016
NW Surrey CCG's MOG agreed the documents attached below providing guidance on monitoring drugs that have been identified as having common adverse drug reactions leading to hospitalisation. The following drugs are covered:
o ACE inhibitors and angiotensin II receptor antagonists
o Digoxin
o NSAIDs (including COX IIs)
o Diuretics
o ACE inhibitors and angiotensin II receptor antagonists
o Digoxin
o NSAIDs (including COX IIs)
o Diuretics
N/A
Documents
Type
Document
Review Date
Supplementary documents (CCG specific documents)
Relevant For
Type
Document
Review Date
Drugs
Below are listed drugs that are used to treat Drug monitoring.
- No records returned.